Inovio Pharmaceuticals Reports Promising Scientific Progress Amid Financial Struggles in Q1 2025
Inovio Pharmaceuticals reported a promising first quarter with scientific advancements, but financial challenges persist, with the company’s stock price remaining below its 52-week high.
3 minutes to read